Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. with a $143.7 million SEC-registered follow-on offering of 4,356,060 shares of...
RAPT Therapeutics’ $143.7 Million Equity Offering
Accuray’s Private Exchange Offers
Davis Polk advised Accuray Incorporated in the deal. Accuray Incorporated executed a private exchange of approximately $82.1 million aggregate principal amount of its outstanding 3.75% convertible...
Ionis Pharmaceuticals’ $632.5 Million Convertible Senior Notes Offering
Davis Polk advised the representatives of the several purchasers in offering. Ionis Pharmaceuticals, Inc. executed its offering of an aggregate principal amount of $632.5 million of its...
Skillz’s $883 Million Stock Offering
Davis Polk advised representatives of the underwriters in the offering. Skillz, Inc. executed its $883 million offering of 36,800,000 shares of Class A common stock, which includes...